Serial Number
87982774
Owner
Caelum Biosciences, Inc.Attorney
Cara M. KearneyFirst Use Date
Jan 1, 2017
Filing Date
Jan 12, 2017
CAELUM BIOSCIENCES Trademark
Serial Number: 87982774 • Registration: 6037766
Trademark Classes
Owner Contact Info
2 Gansevoort Street, 9th Floor
New York, NY 10014
Entity Type: 03
Legal Representation
Correspondence Address
Cara M. Kearney AstraZeneca Pharmaceuticals LP
1800 Concord Pike, A2C
Wilmington, DE 19850-5437
United States
Trademark Details
Filing Date
January 12, 2017
Registration Date
April 21, 2020
First Use Anywhere
January 1, 2017
First Use in Commerce
January 1, 2017
Published for Opposition
December 5, 2017
Goods & Services
Biochemical research and development; Biological research; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Medical research services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical research services; Scientific research consulting in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research consulting in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research consulting in the field of serious and life threatening diseases; Scientific research for medical purposes in the field of amyloidosis and diseases where amyloid deposits are present; Scientific research for medical purposes in the field of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, progressive organ disease and failure; Scientific research for medical purposes in the field of serious and life threatening diseases; Research in the field of pharmacogenetics; Conducting clinical trials for others in the field of pharmaceuticals; Research services in the field of proteins, antibodies, microorganisms and cells; Research and development services in the field of antibody technology; Structural and functional analysis of genomes; DNA screening for scientific research purposes; Biochemical research and analysis; research and development services in the field of immunology
